ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 7,305,761 | $104,472,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $53,961,000 | 89.75% |
| Gruss & Co., LLC | 426,966 | $6,106,000 | 16.39% |
| SB Management Ltd | 9,817,190 | $140,386,000 | 13.88% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $58,703,000 | 5.51% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $45,346,000 | 4.36% |
| Intellectus Partners, LLC | 1,192,379 | $17,051,000 | 4.35% |
| Founders Fund Growth Management, LLC | 407,017 | $5,820,000 | 3.28% |
| ArchPoint Investors | 461,289 | $6,596,000 | 1.96% |
| Belmont Capital, LLC | 150,000 | $2,145,000 | 1.68% |